Compositions of allosteric hemoglobin modifiers and methods...

Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C562S471000

Reexamination Certificate

active

07847120

ABSTRACT:
The present invention provides novel compositions of allosteric hemoglobin modifiers which are substantially free of impurities, specifically polymeric impurities. In one embodiment, the novel compositions contain an allosteric hemoglobin modifier compound and less than 100 ppm of the polymeric impurities generated during the preparation of this compound. Included in the present invention are novel methods for preparing allosteric hemoglobin modifiers that are substantially free of polymeric impurities. Also included in the present invention are improved methods for the purification of the product formed by the method of this invention. The novel methods of purification comprise extracting the crude composition with a water immiscible or partially immiscible solvent such as methylisobutyl ketone (MIBK) to lower amounts of impurities, specifically polymeric impurities. Also included are methods to reduce impurities by recrystallization of the crude synthesized product, followed by filtration of the recrystallized product. The present invention also includes the products made by the processes of the invention and methods for analyzing compositions comprised of these products.

REFERENCES:
patent: 5049695 (1991-09-01), Abraham et al.
patent: 5122539 (1992-06-01), Abraham et al.
patent: 5248785 (1993-09-01), Abraham et al.
patent: 5250701 (1993-10-01), Abraham et al.
patent: 5290803 (1994-03-01), Abraham et al.
patent: 5382680 (1995-01-01), Abraham et al.
patent: 5432191 (1995-07-01), Abraham et al.
patent: 5525630 (1996-06-01), Hoffman
patent: 5591892 (1997-01-01), Abraham et al.
patent: 5648375 (1997-07-01), Abraham
patent: 5661182 (1997-08-01), Abraham et al.
patent: 5665382 (1997-09-01), Grinstaff
patent: 5677330 (1997-10-01), Abraham et al.
patent: 5705521 (1998-01-01), Abraham
patent: 5731454 (1998-03-01), Abraham et al.
patent: 5827888 (1998-10-01), Abraham et al.
patent: 5927283 (1999-07-01), Abraham et al.
patent: 6486342 (2002-11-01), Abraham et al.
patent: 2003/0232887 (2003-12-01), Johnson et al.
patent: 24 32 560 (1976-01-01), None
patent: 2432560 (1976-01-01), None
patent: WO 97/34594 (1997-09-01), None
patent: WO 01/14316 (2001-03-01), None
patent: WO03/086324 (2003-10-01), None
patent: WO 03/092700 (2003-11-01), None
Abraham et al. (1992)Biochemistry31:9141-9149.
Abraham et al. (1998)Med. Chem. Res. 8:478-486.
Amorino et al. (2001)Radiation Research156:294-300.
Grella et al. (2000)Journal Med. Chem. 43:4726-4737.
Kavanagh et al. (2001)Int. J. Radiation Oncology Biol. Phys. 49:1133-1139.
Muguruma et al. (Jul. 1999)LC-GC International, pp. 432-436.
Pagel et al. (1998)Journal of Pharmacology and Experimental Therapeutics285:1-8.
Randad et al. (1991)J. Med. Chem. 34:752-757.
Rockwell and Kelley (1998)Rad. Oncol. Invest. 6:199-208.
Safo et al. (2001)Protein Science10:951-957.
Sarraf-Yazdi et al. (1999)Brain Research826:172-180.
Steffen (1998)Oxygen Transport to Tissue XX454:653-661.
Teicher et al. (1996)Drug Dev. Res. 38(1):1-11.
Teicher et al. (1998)Cancer Chemother. Phamacol. 42:24-30.
Wahr et al. (2001)Anesth. Analg95:615-620.
Watson et al. (1997)Stroke28:1624-1630.
Wireko et al. (1991)Journal of Medicinal Chemistry34:758-767.
Steffen et al. Allosteric Modification of Hemoglobin by RSR13 as a Therapeutic Strategy. Advances in Experimental Medicine and Biology. (2003) 530:249-259.
Chang et al. Diagnosis and Management of Central Nervous System Metastases from Breast Cancer. The Oncologist. (2003) 8 398-410.
Papassotiriou et al. (1998) Experimental Hematology 26:922-926.
Rowinsky (1999) Oncology 10:61-70.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compositions of allosteric hemoglobin modifiers and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions of allosteric hemoglobin modifiers and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of allosteric hemoglobin modifiers and methods... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4238458

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.